Juan Lopez

Contact Info

FOLLOWERS (See All)

  • avatar
  • avatar
05/30/2012 - 2:03pm

Canaccord has published a research report on Monsanto Company (NYSE: MON) and has upgraded the company from Hold to Buy based on the company's announcement that it has increased F12 revenues and 3Q EPS guidance.

In the report, Canaccord writes, "We are upgrading the shares of Monsanto to BUY from Hold previously, and increasing our target price to US

05/30/2012 - 10:50am

Listed below are today's Top Upgrades at Benzinga:

Desjardins Capital Markets Upgrades CGI Group (NYSE: GIB) to Buy:

Desjardins went on to say “Given the outlook for CGI is more positive for 2H FY

05/30/2012 - 10:40am

Listed below are today's Top Downgrades at Benzinga:

Deutsche Bank Downgrades Frontline (NYSE: FRO) to Sell:

Deutsche Bank said, "Market concerns that FRO would be seriously weakened to the benefit

05/30/2012 - 7:20am

Dahlman Rose has published a research report on Agnico-Eagle Mines (NYSE: AEM) and has downgraded the company from Buy to Hold based on valuation.

In the report, Dahlman Rose writes, "Versus our prior estimates, we believe the company could encounter future headwinds due to cost creep, primarily in regards to capex, at both its brownfield and greenfi

05/29/2012 - 2:17pm

Morgan Stanley has published a research report on Vertex Pharmaceuticals (NASDAQ: VRTX) and has lowered the price target from $51 to $46 based on corrected interim CF data that came in weaker than expected.

In the report, Morgan Stanley writes, "We are lowering our VRTX PT to $46 on worse CF data than prev.

05/29/2012 - 12:31pm

Wedbush Securities has published a research report on Facebook (NASDAQ: FB) commenting on the stock performance since the highly anticipated IPO.

In the report, Wedbush writes, "According to Bloomberg, the computer systems used by NASDAQ to set the stock's opening price were overwhelmed by order cancellations and updates, resulting in an imbalance

05/29/2012 - 10:24am

Listed below are today's Top Upgrades at Benzinga:

Wedbush Securities Upgrades Jack in the Box (NASDAQ: JACK) to Neutral:

Wedbush said, "We are raising JACK to NEUTRAL from UNDERPERFORM.

05/29/2012 - 9:25am

Morgan Stanley has opened a research tactical idea on Focus Media (NASDAQ: FMCN) staying that the share price is expected to rise over the next 30 days.

In the report, Morgan Stanley writes, "This is because the stock has traded off recently, making short term valuation much more compelling. We consider Focus Media undervalued.

05/29/2012 - 7:23am

The Benchmark Company has published a research report on InfoSpace (NASDAQ: INSP) after hosting meetings with company management last week.

In the report, Benchmark writes, "InfoSpace recently completed the acquisition of TaxACT.

The Juan Lopez content filter

Quick Stats

Articles Published2740
Total Article Page Views119615
Contributor Since12/2011
Enter your question
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
No questions/answers for the author.
05/30/2012 - 2:03pm

Canaccord has published a research report on Monsanto Company (NYSE: MON) and has upgraded the company from Hold to Buy based on the company's announcement that it has increased F12 revenues and 3Q EPS guidance.

In the report, Canaccord writes, "We are upgrading the shares of Monsanto to BUY from Hold previously, and increasing our target price to US

05/30/2012 - 10:50am

Listed below are today's Top Upgrades at Benzinga:

Desjardins Capital Markets Upgrades CGI Group (NYSE: GIB) to Buy:

Desjardins went on to say “Given the outlook for CGI is more positive for 2H FY

05/30/2012 - 10:40am

Listed below are today's Top Downgrades at Benzinga:

Deutsche Bank Downgrades Frontline (NYSE: FRO) to Sell:

Deutsche Bank said, "Market concerns that FRO would be seriously weakened to the benefit

05/30/2012 - 7:20am

Dahlman Rose has published a research report on Agnico-Eagle Mines (NYSE: AEM) and has downgraded the company from Buy to Hold based on valuation.

In the report, Dahlman Rose writes, "Versus our prior estimates, we believe the company could encounter future headwinds due to cost creep, primarily in regards to capex, at both its brownfield and greenfi

05/29/2012 - 2:17pm

Morgan Stanley has published a research report on Vertex Pharmaceuticals (NASDAQ: VRTX) and has lowered the price target from $51 to $46 based on corrected interim CF data that came in weaker than expected.

In the report, Morgan Stanley writes, "We are lowering our VRTX PT to $46 on worse CF data than prev.

05/29/2012 - 12:31pm

Wedbush Securities has published a research report on Facebook (NASDAQ: FB) commenting on the stock performance since the highly anticipated IPO.

In the report, Wedbush writes, "According to Bloomberg, the computer systems used by NASDAQ to set the stock's opening price were overwhelmed by order cancellations and updates, resulting in an imbalance

05/29/2012 - 10:24am

Listed below are today's Top Upgrades at Benzinga:

Wedbush Securities Upgrades Jack in the Box (NASDAQ: JACK) to Neutral:

Wedbush said, "We are raising JACK to NEUTRAL from UNDERPERFORM.

05/29/2012 - 9:25am

Morgan Stanley has opened a research tactical idea on Focus Media (NASDAQ: FMCN) staying that the share price is expected to rise over the next 30 days.

In the report, Morgan Stanley writes, "This is because the stock has traded off recently, making short term valuation much more compelling. We consider Focus Media undervalued.

05/29/2012 - 7:23am

The Benchmark Company has published a research report on InfoSpace (NASDAQ: INSP) after hosting meetings with company management last week.

In the report, Benchmark writes, "InfoSpace recently completed the acquisition of TaxACT.